Learn About Embryonal Tumor with Multilayered Rosettes
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Duke Children's Health Center Hematology/Oncology Clinic
Susan Kreissman is a Pediatric Hematologist Oncology provider in Durham, North Carolina. Dr. Kreissman is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Hepatoblastoma, Pediatric Low-Grade Glioma (pLGG), and Bone Marrow Aspiration.
Duke Cancer Center Brain Tumor Clinic
Henry Friedman is a Neurosurgery specialist and a Hematologist in Durham, North Carolina. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Friedman is currently accepting new patients.
Duke Cancer Center
Katherine Peters is a Neurologist in Durham, North Carolina. Dr. Peters is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Brain Tumor, and Astrocytoma. Dr. Peters is currently accepting new patients.
Summary: Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to decrease GVHD and PTLD and has demonstrated effectiveness for hematologic malignancies and non-malignant diseases additionally increasing the donor pool as to allow for haploidentical transplant to safely occur. While solid tumors can be h...
Summary: The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the maximum-tolerated dose) and evaluate the occurrence of dose-limiting toxicities (DLTs) following single weekly or multiple-day weekly dose regimens of single-agent, oral ONC206 in patients with recurrent, primary central nervous system (CNS) ne...